UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Dalteparin for prevention of catheter-related complications in cancer patients with central venous catheters: final results of a double-blind, placebo-controlled phase III trial

Annals of oncology, 2006-02, Vol.17 (2), p.289-296

2006

Volltextzugriff (PDF)

Irinotecan in combination with 5-fluorouracil and folinic acid or with cisplatin in patients with advanced gastric or esophageal-gastric junction adenocarcinoma: results of a randomized phase II study

Annals of oncology, 2004-12, Vol.15 (12), p.1773-1781

2004

Volltextzugriff (PDF)

Maintaining Normal Hemoglobin Levels With Epoetin Alfa in Mainly Nonanemic Patients With Metastatic Breast Cancer Receiving First-Line Chemotherapy: A Survival Study

Journal of clinical oncology, 2005-09, Vol.23 (25), p.5960-5972

2005

Volltextzugriff (PDF)

Bortezomib plus Melphalan and Prednisone for Initial Treatment of Multiple Myeloma

The New England journal of medicine, 2008-08, Vol.359 (9), p.906-917

2008

Volltextzugriff (PDF)

Combined pegylated liposomal doxorubicin and bortezomib is highly effective in patients with recurrent or refractory multiple myeloma who received prior thalidomide/lenalidomide therapy

Cancer, 2008-04, Vol.112 (7), p.1529-1537

2008

Volltextzugriff (PDF)

A phase I study of nab -paclitaxel in patients (pts) with advanced solid tumors and hepatic dysfunction

Journal of clinical oncology, 2008-05, Vol.26 (15_suppl), p.13503-13503

2008

Volltextzugriff (PDF)

Pancreatoxicity during neoadjuvant and adjuvant chemotherapy of HER-negative breast cancer

Ėksperimental'nai͡a︡ i klinicheskai͡a︡ gastroėnterologii͡a, 2007 (6), p.38

2007

Volltextzugriff (PDF)

Influence of tumor control on tumor-related events (TRE) in relapsed ovarian cancer (ROC): Results from OVA-301, a randomized phase III study of trabectedin (Tr) with pegylated liposomal doxorubicin (PLD) versus PLD alone

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.e15529-e15529

2010

Volltextzugriff (PDF)

Randomized phase II study of picoplatin in combination with 5-fluorouracil and leucovorin (FOLPI) as a neuropathy-sparing alternative to modified FOLFOX-6 as first-line therapy for colorectal cancer (CRC)

Journal of clinical oncology, 2009-05, Vol.27 (15_suppl), p.4026-4026

2009

Volltextzugriff (PDF)

Phase 1 study of picoplatin (pico) in combination with 5-fluorouracil (FU) and leucovorin (LV) as initial therapy in subjects with metastatic colorectal cancer (CRC)

Journal of clinical oncology, 2007-06, Vol.25 (18_suppl), p.14510-14510

2007

Volltextzugriff (PDF)

PAM50 intrinsic subtyping and pathologic responses to neoadjuvant trastuzumab-based chemotherapy in HER2-positive breast cancer

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.554-554

2011

Volltextzugriff (PDF)

Response to neoadjuvant trastuzumab and chemotherapy in ER+ and ER- HER2-positive breast cancers: Gene expression analysis

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.529-529

2011

Volltextzugriff (PDF)

Tolerability and efficacy of the trifunctional antibody removab® (anti-EpCAM x anti-CD3) in patients with malignant ascites due to ovarian cancer: Results of a phase I/II study

Cancer cell international, 2004-07, Vol.4 (S1), p.S3-S3, Article S3

2004

Volltextzugriff (PDF)

First-line phase Ib and II studies of picoplatin in combination with 5-fluorouracil and leucovorin (FOLPI) as a potential neuropathy-sparing therapy for colorectal cancer (CRC)

Journal of clinical oncology, 2008-05, Vol.26 (15_suppl), p.4100-4100

2008

Volltextzugriff (PDF)

Cytogenetic status of patients with cancer of the gastrointestinal tract before and after treatment

Voprosy onkologij, 2014, Vol.60 (1), p.52

2014

Volltextzugriff (PDF)

A phase II study of pemetrexed plus carboplatin as first-line therapy of patients with locally advanced (LA) or metastatic breast cancer (MBC): Preliminary results

Journal of clinical oncology, 2005-06, Vol.23 (16_suppl), p.694-694

2005

Volltextzugriff (PDF)

Galavit-induced change of immunologic parameters in patients with non-small lung cancer

Voprosy onkologij, 2009, Vol.55 (1), p.51

2009

Volltextzugriff (PDF)

Preliminary data of a phase II randomized trial of taxotere (TXT) and doxorubicin (DOX) given simultaneously or sequentially as 1st line chemotherapy (CT) for metastatic breast cancer (MBC)

European journal of cancer (1990), 1999-09, Vol.35, p.S317-S317

1999

Volltextzugriff (PDF)

The necessity of complex use of radiation and endoscopic techniques in the differential diagnosis of gastric ulcerations

Vestnik rentgenologii i radiologii, 2002-09 (5), p.29

2002

Volltextzugriff (PDF)

The determination of individual sensitivity to cytostatics in breast cancer

Voprosy onkologij, 1995, Vol.41 (2), p.129

1995

Volltextzugriff (PDF)

Comparison of the effectiveness and toxicity of parenteral and oral vepesid in the treatment of disseminated breast cancer

Vestnik Rossiĭskoĭ akademii medits︠i︡nskih nauk, 1995 (4), p.16

1995

Volltextzugriff (PDF)

The degree of tumor vascularization as a prognostic factor of the efficacy of neoadjuvant polychemotherapy in breast cancer

Voprosy onkologij, 1992, Vol.38 (7), p.818

1992

Volltextzugriff (PDF)

Hormonal control of disseminated breast cancer

Sovetskaia meditsina, 1990 (6), p.94

1990

Volltextzugriff (PDF)

Non-adjuvant chemotherapy in the complex treatment of breast cancer

Sovetskaia meditsina, 1988 (10), p.96

1988

Volltextzugriff (PDF)

CD24 Ala57Val polymorphism predicts pathologic complete response to sequential anthracycline- and taxane-based neoadjuvant chemotherapy for primary breast cancer

Breast cancer research and treatment, 2012-04, Vol.132 (3), p.819-831

2012

Volltextzugriff (PDF)

1 – 25 von 27

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(25)
Mit Volltextzugriff
(18)

Publikationsform

Artikel
(27)

Sprache

Englisch
(17)
Russisch
(10)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

Dalteparin for prevention of catheter-related complications in cancer patients with central venous catheters: final results of a double-blind, placebo-controlled phase III trial

Irinotecan in combination with 5-fluorouracil and folinic acid or with cisplatin in patients with advanced gastric or esophageal-gastric junction adenocarcinoma: results of a randomized phase II study

Maintaining Normal Hemoglobin Levels With Epoetin Alfa in Mainly Nonanemic Patients With Metastatic Breast Cancer Receiving First-Line Chemotherapy: A Survival Study

Bortezomib plus Melphalan and Prednisone for Initial Treatment of Multiple Myeloma

Combined pegylated liposomal doxorubicin and bortezomib is highly effective in patients with recurrent or refractory multiple myeloma who received prior thalidomide/lenalidomide therapy

A phase I study of nab -paclitaxel in patients (pts) with advanced solid tumors and hepatic dysfunction

Pancreatoxicity during neoadjuvant and adjuvant chemotherapy of HER-negative breast cancer

Influence of tumor control on tumor-related events (TRE) in relapsed ovarian cancer (ROC): Results from OVA-301, a randomized phase III study of trabectedin (Tr) with pegylated liposomal doxorubicin (PLD) versus PLD alone

Randomized phase II study of picoplatin in combination with 5-fluorouracil and leucovorin (FOLPI) as a neuropathy-sparing alternative to modified FOLFOX-6 as first-line therapy for colorectal cancer (CRC)

Phase 1 study of picoplatin (pico) in combination with 5-fluorouracil (FU) and leucovorin (LV) as initial therapy in subjects with metastatic colorectal cancer (CRC)

PAM50 intrinsic subtyping and pathologic responses to neoadjuvant trastuzumab-based chemotherapy in HER2-positive breast cancer

Response to neoadjuvant trastuzumab and chemotherapy in ER+ and ER- HER2-positive breast cancers: Gene expression analysis

Tolerability and efficacy of the trifunctional antibody removab® (anti-EpCAM x anti-CD3) in patients with malignant ascites due to ovarian cancer: Results of a phase I/II study

First-line phase Ib and II studies of picoplatin in combination with 5-fluorouracil and leucovorin (FOLPI) as a potential neuropathy-sparing therapy for colorectal cancer (CRC)

Cytogenetic status of patients with cancer of the gastrointestinal tract before and after treatment

A phase II study of pemetrexed plus carboplatin as first-line therapy of patients with locally advanced (LA) or metastatic breast cancer (MBC): Preliminary results

Galavit-induced change of immunologic parameters in patients with non-small lung cancer

Preliminary data of a phase II randomized trial of taxotere (TXT) and doxorubicin (DOX) given simultaneously or sequentially as 1st line chemotherapy (CT) for metastatic breast cancer (MBC)

The necessity of complex use of radiation and endoscopic techniques in the differential diagnosis of gastric ulcerations

The determination of individual sensitivity to cytostatics in breast cancer

Comparison of the effectiveness and toxicity of parenteral and oral vepesid in the treatment of disseminated breast cancer

The degree of tumor vascularization as a prognostic factor of the efficacy of neoadjuvant polychemotherapy in breast cancer

Hormonal control of disseminated breast cancer

Non-adjuvant chemotherapy in the complex treatment of breast cancer

CD24 Ala57Val polymorphism predicts pathologic complete response to sequential anthracycline- and taxane-based neoadjuvant chemotherapy for primary breast cancer

Suchergebnisse filtern